Lazari Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $692K | Sell |
18,021
-89
| -0.5% | -$3.42K | 0.26% | 61 |
|
|
2025
Q1 | $702K | Sell |
18,110
-1,302
| -7% | -$50.4K | 0.29% | 56 |
|
|
2024
Q4 | $657K | Sell |
19,412
-134
| -0.7% | -$4.53K | 0.26% | 62 |
|
|
2024
Q3 | $799K | Sell |
19,546
-424
| -2% | -$17.3K | 0.34% | 51 |
|
|
2024
Q2 | $769K | Buy |
19,970
+486
| +2% | +$18.7K | 0.35% | 51 |
|
|
2024
Q1 | $835K | Sell |
19,484
-720
| -4% | -$30.9K | 0.45% | 37 |
|
|
2023
Q4 | $749K | Sell |
20,204
-11,600
| -36% | -$430K | 0.43% | 38 |
|
|
2023
Q3 | $1.15M | Sell |
31,804
-60
| -0.2% | -$2.18K | 0.69% | 28 |
|
|
2023
Q2 | $1.14M | Buy |
+31,864
| New | +$1.14M | 0.64% | 30 |
|